• Dec 16, 2024

What's Going On With Illumina Stock On Monday?

On Friday, Nasdaq Inc’s (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH). The provider of DNA sequencing and array-based technologies has been in the news due to its controversial multi-billion dollar deal to acquire cancer test maker Grail Inc (NASDAQ:GRAL). Also

  • Dec 16, 2024

What's Going On With Moderna Stock On Monday?

On Friday, Nasdaq Inc's (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. As a result, Moderna Inc. (NASDAQ:MRNA) was removed from the index. Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from Benzinga Pro. Recently, Moderna and several other stocks witnessed a decline as Robert F. Kennedy Jr.'s, Donald Trump's nomination to lead the Department of Health and Human Ser

  • Dec 16, 2024

Grindr's Expanding LGBTQ+ Market and 20% Revenue Growth Impresses Goldman Sachs

Goldman Sachs analyst Eric Sheridan initiated coverage on Grindr Inc (NYSE:GRND) with a Buy rating and a price target of $20. Grindr is an online dating platform primarily focused on serving the LGBTQ+ community with 14.6 million monthly active users (as of the third quarter of 2024) globally. In this initiation, Sheridan framed his work around three key debates for Grindr stock, including the company’s addressable market, whether it achieves a 20%+ fiscal 2024-2029 revenue CAGR, and whether it